Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mohammed A. Dahab, Hazem A. Mahdy, Hazem Elkady, Mohammed S. Taghour, Alaa Elwan, Mohamed A. Elkady, Elsayed G. E. Elsakka, Eslam B. Elkaeed, Aisha A. Alsfouk, Ibrahim M. Ibrahim, Ahmed M. Metwaly & Ibrahim H. Eissa. (2023) Semi-synthesized anticancer theobromine derivatives targeting VEGFR-2: in silico and in vitro evaluations. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-20.
Read now
Read now
Articles from other publishers (2)
Radwa Ayman, Moustafa S. Abusaif, A.M. Radwan, Amira M. Elmetwally & Ahmed Ragab. (2023) Development of novel pyrazole, imidazo[1,2-b]pyrazole, and pyrazolo[1,5-a]pyrimidine derivatives as a new class of COX-2 inhibitors with immunomodulatory potential. European Journal of Medicinal Chemistry 249, pages 115138.
Crossref
Crossref
Derya Osmaniye, Begüm Nurpelin Sağlık, Narmin Khalilova, Serkan Levent, Gizem Bayazıt, Ülküye Dudu Gül, Yusuf Özkay & Zafer Asım Kaplancıklı. (2023) Design, Synthesis, and Biological Evaluation Studies of Novel Naphthalene-Chalcone Hybrids As Antimicrobial, Anticandidal, Anticancer, and VEGFR-2 Inhibitors. ACS Omega 8:7, pages 6669-6678.
Crossref
Crossref